SCHEMBL4833262

SCHEMBL4833262

COC(=O)c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3cc(C(F)(F)F)ccc3Cl)cc2)cc1C(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
RORC P51449 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
POLB P06746 2/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MAPT P10636 1/20 0.34
GNRHR P30968 1/20 0.34
MMP8 P22894 6/20 0.34
MMP3 P08254 3/20 0.34
TRPA1 O75762 1/20 0.34
PTGER3 P43115 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4840740 0.95 FFAR4 (0.39) ATMFFAR4RORCSMN1; SMN2ALDH1A1
SCHEMBL4845736 0.94 FFAR4 (0.41) FFAR4RORCALDH1A1NPSR1MMP8
SCHEMBL4838705 0.94 FFAR4 (0.38) ATMFFAR4RORCSMN1; SMN2ALDH1A1
SCHEMBL4833834 0.90 FFAR4 (0.39) FFAR4RORCSMN1; SMN2ALDH1A1NPSR1
SCHEMBL4840278 0.90 RORC (0.40) RORCALDH1A1NPSR1MMP8MMP3
SCHEMBL4841148 0.90 FFAR4 (0.41) FFAR4RORCALDH1A1NPSR1MMP8
SCHEMBL4842178 0.88 PTGER3 (0.37) ATMFFAR4RORCSMN1; SMN2MAPT
SCHEMBL4843610 0.88 RORC (0.41) RORCALDH1A1NPSR1MAPTMMP8
SCHEMBL4842917 0.88 FFAR4 (0.41) ATMFFAR4RORCSMN1; SMN2ALDH1A1
SCHEMBL4837553 0.87 FFAR4 (0.40) FFAR4RORCSMN1; SMN2ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 ATM 1808/4885FFAR4 125/4885RORC 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.